Medication info
Olmesartan Medoxomil 10 mg Tablets

Olmesartan Medoxomil 10 mg Tablets

Prescription medicationTabletOral
Ingredient · strength
Olmesartan Medoxomil›10mg / 1 tablet
Manufacturer / importer
Ildong Pharmaceutical Co., Ltd.
Appearance
White round film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 201306917 · Approved 2013.04.16 · Insurance code 642904770

Summary

Main use
Treatment of essential hypertension
Who takes it
Adults · Children
Adult dose
<Adults> The recommended initial dose is 10mg once daily, administered with or without food. If blood pressure is not adequately controlled at this dose, increase the dose to 20mg once daily. If further blood pressure reduction is required, the dose may be increased to a maximum of 40mg once daily. The blood pressure-lowering effect appears within 2 weeks after treatment is started and reaches its maximum after approximately 8 weeks. If blood pressure is not adequately controlled with this medicine alone, it may be used in combination with a thiazide diuretic such as hydrochlorothiazide. To improve adherence, it is recommended that the medicine be taken at the same time each day (e.g., in the morning), if possible. For patients who may have intravascular volume depletion (e.g., patients receiving diuretics, especially those with renal impairment), it is recommended that treatment be initiated at a low dose while their condition is closely monitored. <Elderly patients> No dose adjustment is necessary when this medicine is administered to patients aged 65 years or older. No overall differences in efficacy or safety have been observed between elderly and younger patients; however, a more pronounced response in some elderly patients cannot be ruled out. <Patients with renal impairment> The maximum dose for patients with mild or moderate renal impairment (creatinine clearance 20-60mL/min) is 20mg once daily. <Patients with hepatic impairment> No dose adjustment is necessary for patients with mild hepatic impairment. The recommended initial dose for patients with moderate hepatic impairment is 10mg once daily, which may be increased to a maximum of 20mg once daily. Since there is no experience with use in patients with severe hepatic impairment, administration of this medicine is not recommended.
Child dose
<Children> The safety and efficacy in children have not been established.

Ingredients

Manufacturer
Ildong Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension

  • Essential hypertension
View approved original text

Essential hypertension is a condition characterized by persistently elevated blood pressure, placing burden on the heart and blood vessels. This medication effectively lowers blood pressure, helping to prevent complications such as heart disease or stroke. It aids in the stable management of blood pressure when taken regularly and alleviates symptoms caused by essential hypertension, thereby improving the patient's quality of life. Therefore, it is used for the treatment of essential hypertension.

How to take

Adult dose

<Adults> The recommended initial dose is 10mg once daily, administered with or without food. If blood pressure is not adequately controlled at this dose, increase the dose to 20mg once daily. If further blood pressure reduction is required, the dose may be increased to a maximum of 40mg once daily. The blood pressure-lowering effect appears within 2 weeks after treatment is started and reaches its maximum after approximately 8 weeks. If blood pressure is not adequately controlled with this medicine alone, it may be used in combination with a thiazide diuretic such as hydrochlorothiazide. To improve adherence, it is recommended that the medicine be taken at the same time each day (e.g., in the morning), if possible. For patients who may have intravascular volume depletion (e.g., patients receiving diuretics, especially those with renal impairment), it is recommended that treatment be initiated at a low dose while their condition is closely monitored. <Elderly patients> No dose adjustment is necessary when this medicine is administered to patients aged 65 years or older. No overall differences in efficacy or safety have been observed between elderly and younger patients; however, a more pronounced response in some elderly patients cannot be ruled out. <Patients with renal impairment> The maximum dose for patients with mild or moderate renal impairment (creatinine clearance 20-60mL/min) is 20mg once daily. <Patients with hepatic impairment> No dose adjustment is necessary for patients with mild hepatic impairment. The recommended initial dose for patients with moderate hepatic impairment is 10mg once daily, which may be increased to a maximum of 20mg once daily. Since there is no experience with use in patients with severe hepatic impairment, administration of this medicine is not recommended.

Child dose

<Children> The safety and efficacy in children have not been established.

Precautions

This medication can cause serious harm or death to the fetus and newborn if administered to pregnant women in the second and third trimesters, so it must be discontinued immediately upon confirmation of pregnancy. This medication should not be used in certain patients. For example, individuals allergic to this medication or its components, pregnant or breastfeeding women, patients on kidney dialysis, those with severe liver impairment, biliary obstruction, lactose intolerance or related genetic disorders, certain diabetic patients, and patients with severely reduced kidney function should not take this medication. Hypotension can occur in patients with reduced blood volume or body salts, so the pre-treatment status should be thoroughly checked, and careful monitoring should continue during treatment. This medication may affect kidney function, so patients with weakened kidney function or transplant recipients should frequently check their kidney status through blood tests, and its use is not recommended in cases of severe kidney impairment. Patients with renal artery stenosis, at risk of hyperkalemia, or those with aortic or cardiac valve disease require special caution when taking this medication. During treatment, blood pressure can drop and cause dizziness, so it is advisable to avoid driving or operating hazardous machinery. The blood pressure-lowering effect of this medication may vary among different ethnic groups, and it may be less effective in Black patients. The side effects of this medication are generally mild and temporary, with dizziness being the most common. Other potential side effects include abdominal pain, headache, muscle pain, rash, and hyperkalemia. Taking this medication during pregnancy may lead to decreased kidney function in the fetus, resulting in reduced amniotic fluid volume and various malformations or developmental disorders; thus, it should not be taken during pregnancy. Breastfeeding women should exercise caution, as this medication may pass into breast milk, potentially causing adverse reactions in the baby, and breastfeeding should be interrupted or medication stopped if necessary. Safety and efficacy in children have not been sufficiently established, so it should be administered cautiously in this population. In elderly patients, the medication may remain in the body for a longer period, requiring dosage adjustments and careful monitoring. In case of overdose, blood pressure decrease and heart rhythm abnormalities may occur, requiring immediate treatment and supportive therapy if necessary. This medication may interact with other drugs, so caution is necessary, especially when taken with potassium-sparing diuretics, lithium, or non-steroidal anti-inflammatory drugs. Rare gastrointestinal disorders similar to chronic malabsorption syndrome have been reported, so if severe diarrhea or weight loss occurs during long-term use, consult a doctor. If any abnormal symptoms occur during treatment, immediate consultation with medical personnel is necessary for appropriate measures.

Side effects

  • Dizziness
  • low back pain
  • bronchitis
  • increased creatine phosphokinase
  • diarrhea
  • headache
  • hematuria
  • hyperglycemia
  • hypertriglyceridemia
  • influenza-like symptoms
Show 38 more
  • pharyngitis
  • rhinitis
  • sinusitis
  • cough
  • chest pain
  • peripheral edema
  • vertigo
  • abdominal pain
  • dyspepsia
  • gastritis
  • nausea
  • palpitations
  • hypercholesterolemia
  • hyperlipidemia
  • hyperuricemia
  • arthralgia
  • arthritis
  • myalgia
  • rash
  • facial edema
  • asthenia
  • vascular edema
  • anaphylactic reaction
  • vomiting
  • chronic malabsorption syndrome
  • intestinal vascular edema
  • rhabdomyolysis
  • hyperkalemia
  • acute kidney failure
  • elevated serum creatinine
  • hair loss
  • pruritus
  • urticaria
  • autoimmune hepatitis
  • headache
  • hypertension
  • epistaxis
  • asthma

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to avoid exposure to air and moisture. It is important to maintain the storage temperature between 1 and 25 degrees Celsius.

Appearance and packaging

Appearance

White round film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.